Table:
begin	end	state
1	28	cytoplasmic
29	50	transmembrane
51	59	non-cytoplasmic
60	81	transmembrane
82	99	cytoplasmic
100	125	transmembrane
126	157	non-cytoplasmic
158	177	transmembrane
178	184	cytoplasmic
185	207	transmembrane
208	218	non-cytoplasmic
219	238	transmembrane
239	258	cytoplasmic
259	284	transmembrane
285	304	non-cytoplasmic
305	333	transmembrane
334	355	cytoplasmic
356	375	transmembrane
376	380	non-cytoplasmic
381	400	transmembrane
401	411	cytoplasmic
412	432	transmembrane
433	437	non-cytoplasmic
438	457	transmembrane
458	465	cytoplasmic

Input:
>WP_041675872.1 NCBI__GCF_000021545.1:WP_041675872.1
MQEVSVKDFFRKRYYDGIKDTKLKRSLGLWDLVFIGVGGIIGAGIFVITGQAAAAYAGPG
IILSFVLSAIAIGITALVYAEFSSAFPISGSAYSYTYATLGEVIAWLVAWNILLEYGVAA
AAVATGWSGYLRTFLENNFGFTLPVALSGAFDPSKGTVIDLFAFLGMAGVFALLTIGIKE
SARVNFFIVLLKLAVLLVFIFIGLKYVKLENITSNFLPYGWQGVWSAASLIVFAYLGFDA
VSTLAEETKDPQKTLPKGLILSLSISTVLYITVSFVLVGILPYYSYEGKPDSLAYAMYQV
NEKWVADFISLGAVITITSVMIVMGLGFTRVLYSLARDRLFFKTFADIHPKFNTPYKASI
LGGVFLSVLAGFLPLKILAEMVNIGTLFAYFMVGVAAIVIKNRPDIRPIFKVPYPNLLLP
LNLIFLMFIMAGLPFDTWMRFFIWTIIGILIYFFYGYKNSILGKS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server